DHA reduces the atrophy-associated Fn14 protein in differentiated myotubes during coculture with macrophages

Brian S Finlin1, Vijayalakshmi Varma, Greg T Nolen

  • 1The Department of Medicine, Division of Endocrinology, University of Kentucky, Lexington, KY 40536, USA.

Insights

Docosahexaenoic acid (DHA) may protect muscle mass by inhibiting macrophage-induced expression of Fn14, a receptor linked to muscle atrophy. This suggests a potential therapeutic role for DHA in combating obesity-related muscle complications.

Area of Science:

  • Muscle biology
  • Immunology
  • Metabolic disease

Background:

  • Macrophages are crucial for muscle repair and regeneration.
  • Increased muscle macrophages in obesity correlate with insulin resistance.
  • Macrophage-myotube coculture impairs insulin signaling and induces atrophy.

Purpose of the Study:

  • To investigate the effect of docosahexaenoic acid (DHA) on muscle-macrophage cocultures.
  • To test if DHA counteracts palmitic acid's negative effects on muscle cells.

Main Methods:

  • Coculture of human muscle cells with macrophages.
  • Treatment with docosahexaenoic acid (DHA).
  • Analysis of insulin signaling, atrophy pathways, and Fn14/MuRF-1 expression.

Main Results:

  • DHA did not improve insulin signaling in cocultured muscle cells.
  • DHA inhibited the expression of the Fn14 receptor.
  • DHA treatment led to post-translational modification of MuRF-1 (muscle ring-finger protein-1).

Conclusions:

  • DHA may preserve muscle mass by inhibiting macrophage-induced Fn14 expression.
  • This mechanism suggests a potential benefit of DHA in obesity-related muscle conditions.

Related Concept Videos